Literature DB >> 2666802

Cholecystokinin and gastrin antagonists.

R M Freidinger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2666802     DOI： 10.1002/med.2610090303

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  6 in total

1.  Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.

Authors:  A Schmassmann; A Garner; B Flogerzi; M Y Hasan; M Sanner; L Varga; F Halter
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

2.  Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.

Authors:  Eyup Akgün; Meike Körner; Fan Gao; Kaleeckal G Harikumar; Beatrice Waser; Jean Claude Reubi; Philip S Portoghese; Laurence J Miller
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

3.  Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line.

Authors:  R Jamshidipour; E B Pinho; D K Hom; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

Review 5.  Neurobiological investigations into the role of cholecystokinin in panic disorder.

Authors:  J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

6.  The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches.

Authors:  L J Miller
Journal:  Yale J Biol Med       Date:  1992 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.